Peritoneal dissemination associated with the postoperative recurrence of breast cancer is relatively low (3–6%). Although the prognosis of patients with peritoneal metastasis is generally short (7–26 months), we experienced a unique case in which complete remission was achieved for more than 6 years with endocrine therapy alone.
CITATION STYLE
Fuke, A., Tabei, I., Okamoto, T., & Takeyama, H. (2020). Complete remission from peritoneal metastasis of late recurrent breast cancer by endocrine therapy: a case report. Surgical Case Reports, 6(1). https://doi.org/10.1186/s40792-020-01002-9
Mendeley helps you to discover research relevant for your work.